Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis

BACKGROUND: Short-acting β2-agonist (SABA) nebulization is commonly prescribed for children hospitalized with severe asthma exacerbation. Either intermittent or continuous delivery has been considered safe and efficient. The comparative efficacy of these two modalities is inconclusive. We aimed to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulalert, Prapasri, Phinyo, Phichayut, Patumanond, Jayanton, Smathakanee, Chutima, Chuenjit, Wantida, Nanthapisal, Sira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329360/
https://www.ncbi.nlm.nih.gov/pubmed/32632352
http://dx.doi.org/10.1186/s40733-020-00059-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329360/
https://www.ncbi.nlm.nih.gov/pubmed/32632352
http://dx.doi.org/10.1186/s40733-020-00059-5

Ejemplares similares